Candel Therapeutics Inc (CADL)

Candel Therapeutics Inc (CADL) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $709M; returns 1 day -4.2%, 1 week -2.0%, 1 year +51.2%.

Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer. They are developing viral immunotherapies designed to cause in situ immunization against tumor cells and stimulate the immune system.

Groups CADL belongs to

• Healthcare
• Biotechnology
• Biopharmaceutical
• Clinical Stage
• Clinical Stage Biotech
• Oncology
• Cancer Therapeutics
• Immunotherapy
• Gene Therapy
• Life Sciences
• Pancreatic Cancer
• Unmet Medical Needs

CADL financial model: income statement, cash flow and balance sheet